MONDAY, Jan. 17, 2022 (HealthDay News) — U.S. insurers are paying millions of dollars a year to cover the cost of ivermectin for COVID-19 patients despite a lack of proof the anti-parasitic drug is effective against the virus, a new study finds. Both the U.S. Food and Drug Administration andContinue Reading

MONDAY, Jan. 17, 2022 (HealthDay News) — Parents struggling with infant feeding issues may have another reason to persevere: New research ties feeding problems with an increased risk of developmental delays. For the study, the mothers of nearly 3,600 children were surveyed about feeding problems at 18, 24 and 30Continue Reading

MONDAY, Jan. 10, 2022 (HealthDay News) — Researchers say they’ve uncovered a clue to why the Omicron variant spreads COVID-19 so much more rapidly than its predecessors. People who are infected but have no symptoms are still far more likely to infect others than they would have been with earlierContinue Reading

MONDAY, Jan. 10, 2022 (HealthDay News) — For people newly diagnosed with advanced melanoma, a combination of two immunotherapy drugs can double the amount of time their cancer remains progression-free, a clinical trial has found. The treatment combines two drugs known as immune checkpoint inhibitors. One, called nivolumab (Opdivo), isContinue Reading

MONDAY, Jan. 10, 2022 (HealthDay News) — Vaccination is still the best way to protect someone from COVID-19, but new research suggests that immune system activation of T-cells by common colds may offer some cross-protection. The study might also provide a blueprint for a second-generation, universal vaccine that could preventContinue Reading